InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,988.68
(
0.08%
)
US TECH 100
20,493.20
(
-0.11%
)
Dow Jones
44,071.43
(
0.37%
)
Brent Oil
72.07
(
0.63%
)
Bitcoin
91,867.77
(
4.49%
)
Post# of 253588
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: None

Thursday, 12/08/2005 4:11:11 PM

Thursday, December 08, 2005 4:11:11 PM

Post# of 253588
YMI--promise-keeping enterprise?

If you've seen the corporate presentation, you know what I'm talking about.

This is what's due Q4 2005:

- Meet with FDA regarding Nimotuzumab / approval for Phase III in US with Nimotuzumab (?)
– European approval of pivotal Phase III trial- children
– Stomach cancer trial IND approval with Tesmilifene
– Initiate NSCLC trial – patients unfit for chemotherapy
– Initiate Taxotere/Tesmilifene trial metastatic breast cancer

Haven't seen any of it yet.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up